C57BL/6NCya-Kdm4bem1flox/Cya
Common Name:
Kdm4b-flox
Product ID:
S-CKO-04688
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Kdm4b-flox
Strain ID
CKOCMP-193796-Kdm4b-B6N-VA
Gene Name
Product ID
S-CKO-04688
Gene Alias
4732474L06Rik; Jmjd2b
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
17
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Kdm4bem1flox/Cya mice (Catalog S-CKO-04688) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000025036
NCBI RefSeq
NM_172132
Target Region
Exon 5
Size of Effective Region
~1.7 kb
Detailed Document
Overview of Gene Research
Kdm4b, a member of the KDM4 family also known as JMJD2, is a lysine-specific demethylase. It specifically targets di-and tri-methylated lysine 9 on histone H3 (H3K9me3), reversing a modification crucial for heterochromatin definition and gene repression. This histone demethylation process is involved in regulating nuclear processes like gene transcription, DNA replication, and repair, and is important for normal development and can contribute to cancer progression [1,4,5].
In skeletal aging, loss-of-function of Kdm4b in mesenchymal stromal cells (MSCs) exacerbates the bone-fat imbalance and MSC exhaustion. Kdm4b-deficient MSCs show reduced bone formation, increased marrow adiposity, and impaired self-renewal due to increased H3K9me3 and senescence-associated heterochromatin foci formation [2]. In oral bones, loss of Kdm4b in oral MSCs (OMSCs) inhibits osteogenesis, promotes adipogenesis and OMSC senescence, disturbing the bone-fat balance in the mandible [7].
In a heterozygous mouse model of Kdm4b (Kdm4b+/-), disruptions lead to reduced total brain volume, decreased hippocampal dentate gyrus size, partial agenesis of the corpus callosum, and ventriculomegaly, mirroring the global developmental delay and neuroanatomical defects seen in humans with Kdm4b variants [3].
In glioblastoma, silencing Kdm4B inhibits cell survival, proliferation, migration, and invasion, suggesting its essential role in tumorigenic activity [6]. In prostate cancer, knockdown of Kdm4B significantly inhibits cell proliferation, while its overexpression promotes cell proliferation by activating autophagy [8]. In uterine corpus endometrial carcinoma, Kdm4B is overexpressed and associated with poor prognosis, and is enriched in immune-related biological processes and signaling pathways [9].
In conclusion, Kdm4b plays diverse and crucial roles in normal development and disease through its histone demethylation function. Studies using gene knockout (KO) or conditional knockout (CKO) mouse models have revealed its significance in skeletal aging, neurodevelopment, and cancer progression. These findings enhance our understanding of the underlying mechanisms and provide potential therapeutic targets for related diseases.
References:
1. Wilson, Cailin, Krieg, Adam J. 2019. KDM4B: A Nail for Every Hammer? In Genes, 10, . doi:10.3390/genes10020134. https://pubmed.ncbi.nlm.nih.gov/30759871/
2. Deng, Peng, Yuan, Quan, Cheng, Yingduan, Yu, Bo, Wang, Cun-Yu. 2021. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. In Cell stem cell, 28, 1057-1073.e7. doi:10.1016/j.stem.2021.01.010. https://pubmed.ncbi.nlm.nih.gov/33571444/
3. Duncan, Anna R, Vitobello, Antonio, Collins, Stephan C, Yalcin, Binnaz, Agrawal, Pankaj B. 2020. Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects. In American journal of human genetics, 107, 1170-1177. doi:10.1016/j.ajhg.2020.11.001. https://pubmed.ncbi.nlm.nih.gov/33232677/
4. Ni, Fangjing, Tang, Heting, Cheng, Siteng, Zhang, Encheng, Wang, Xiang. 2023. KDM4B: A promising oncology therapeutic target. In Cancer science, 115, 8-16. doi:10.1111/cas.16005. https://pubmed.ncbi.nlm.nih.gov/37923555/
5. Wang, Zhongze, Cai, Huarui, Zhao, Erhu, Cui, Hongjuan. 2022. The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression. In Frontiers in cell and developmental biology, 9, 790129. doi:10.3389/fcell.2021.790129. https://pubmed.ncbi.nlm.nih.gov/35186950/
6. Wang, Zhongze, Cai, Huarui, Li, Zekun, Zhao, Erhu, Cui, Hongjuan. 2023. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability. In Clinical epigenetics, 15, 192. doi:10.1186/s13148-023-01608-4. https://pubmed.ncbi.nlm.nih.gov/38093312/
7. Deng, Peng, Chang, Insoon, Wang, Jiongke, Yu, Bo, Wang, Cun-Yu. 2022. Loss of KDM4B impairs osteogenic differentiation of OMSCs and promotes oral bone aging. In International journal of oral science, 14, 24. doi:10.1038/s41368-022-00175-3. https://pubmed.ncbi.nlm.nih.gov/35525910/
8. Sha, Jianjun, Han, Qing, Chi, Chenfei, Xia, Weiliang, Xue, Wei. 2019. Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy. In Journal of cellular physiology, 235, 2129-2138. doi:10.1002/jcp.29117. https://pubmed.ncbi.nlm.nih.gov/31468537/
9. Zhang, Mengjun, Liu, Yuan, Hou, Siyu, Yin, Yue, Chen, Xiuwei. 2022. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma. In Molecular omics, 18, 506-519. doi:10.1039/d1mo00287b. https://pubmed.ncbi.nlm.nih.gov/35485290/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen